A p p e n d i x 4 E Preliminary Final Report 30 June 2026 1. Company Details INVEX THERAPEUTICS LTD ABN 29 632 145 334 Report ending 30 June 2026 Corresponding period 30 June 2025 R e s u l t s f o r a n n o u n c e m e n t t o t h e m a r k e t June...